COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients
The Montreal Heart Institute (MHI) announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine. The […]
COVID-19 patients who are overweight or obese are more likely to develop a more severe infection than patients of healthy […] Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] Evolutionary ecology theory offers avenues to anticipate the future behavior of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. […] A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […] A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […] The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, has claimed […] With over 127.8 million cases of coronavirus disease 2019 (COVID-19) already documented, and many more millions that have undoubtedly gone […] Many viruses infect their hosts through mucosal surfaces such as the lining of the respiratory tract. MIT researchers have now […]respiratory
COVID-19 patients who are overweight or obese may develop a more severe infection
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
Can universal vaccines and treatments against future SARS-CoV-2 variants be developed?
Researchers develop novel test that screens for SARS-CoV-2 variants of concern
Researchers develop novel test that screens for SARS-CoV-2 variants of concern
Long-COVID-19 is a significant risk in recovered patients post-hospitalization
Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer: study